Sildenafil Tablet
Product Images NDC 82009-094

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 82009-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg (Sildenafil 20mg)

Sildenafil Tablets, USP 20 mg oral tablets label showing a package size of 90 tablets. The label lists Ajanta Pharma Limited as the manufacturer and Quallent Pharmaceuticals Health LLC as the labeler. The label includes storage instructions, dosage reference, child-resistant packaging note, and a barcode with the NDC 82009-094-90. The label is predominantly white with green and black text, and a designated unvarnish area is marked.*

FDA Label Image

Figure1 (Sildenafil Fig1)

A forest plot chart depicting drug interaction recommendations for Sildenafil tablets 20 mg when co-administered with various drugs and oral contraceptives. The chart shows the change relative to Sildenafil alone for AUC and Cmax with 90% confidence intervals, indicating whether dose adjustment or coadministration is recommended or not.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A forest plot depicting fold change and 95% confidence intervals for the interaction of Sildenafil 20 mg tablets with various coadministered drugs. The chart compares changes in AUC and Cmax relative to Sildenafil alone, along with dosing recommendations such as no dose adjustment or cautionary notes on coadministration.*

FDA Label Image

Figure3 (Sildenafil Fig3)

A line chart illustrating changes from baseline in a measured variable (likely renal function) over weeks 0, 4, and 12 during a study. It compares three groups: Sildenafil 40 mg TID, Sildenafil 80 mg TID, and placebo, with error bars indicating variability at each time point.*

FDA Label Image

Figure4 (Sildenafil Fig4)

A horizontal forest plot illustrating placebo-corrected changes in 6-minute walk distance across various subgroups of patients treated with Sildenafil 20 mg TID compared to placebo. Subgroups include baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean PAP, and PVR. Each subgroup is shown with a point estimate and confidence interval.*

FDA Label Image

Figure5 (Sildenafil Fig5)

A line graph depicting the percentage of ELI100a clinically screening levels over days from randomization (0 to 112 days). Two lines represent data for Placebo and Sildenafil groups, showing the variation of the percentage over time for each group.*

FDA Label Image

Logo (Sildenafil Logo)

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure diagram of sildenafil, showing its molecular framework including rings, nitrogen, oxygen, and sulfur atoms, consistent with the active ingredient sildenafil in the product label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.